Edition:
United States

Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.40USD
24 May 2019
Change (% chg)

-- (--)
Prev Close
$0.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
470,318
52-wk High
$0.83
52-wk Low
$0.27

About

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other... (more)

Overall

Beta: 0.20
Market Cap(Mil.): ₪286.19
Shares Outstanding(Mil.): 133.35
Dividend: --
Yield (%): --

Financials

  PLX Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.00 -- --
ROI: -127.90 8.91 13.82
ROE: -- 10.05 15.24

Earnings vs. Estimates